News Release: Hemedex, Inc. Sponsors Live Webinar on The Clinical Utility of Quantifying Cerebral Blood Flow

Posted by on Jan 2, 2014 in News Releases

News Release: Hemedex, Inc. Sponsors Live Webinar on The Clinical Utility of Quantifying Cerebral Blood Flow

CAMBRIDGE, Mass. (January 2, 2014) – Hemedex, Inc. will be sponsoring a live webinar with Business Review Webinars on February 27th, 2014 3PM London/10AM New York.  The webinar’s main focus is discussing the features and benefits of using the Bowman Perfusion Monitor in Neurocritical Care and Neurosurgery.

Many neurocritical care patients needlessly suffer severe complications or death resulting from undetected ischemia. There is a need to continuously measure cerebral blood flow in absolute units at the bedside. The Bowman Perfusion Monitor is the only medical device that meets this need.

The webinar will address:

  • The clinical utility of monitoring cerebral blood flow (CBF) and its use in clinical decision making
  • Real-time detection of critical levels of CBF using thresholds
  • Assess state of cerebral autoregulation
  • Differentiate vasospasam and hyperemia during elevated TCD measurements
  • Assess the effects of interventions on CBF
  • Provides information to help reduce risk of neurological complications
  • CBF as a predictor of patient outcomes
  • Role of CBF monitoring in Multi-Modal Monitoring
  • The features and benefits of using the Bowman Perfusion Monitor
  • Neurocritical care applications: SAH, TBI, ICH
  • Neurosurgical applications: Aneurysm repair(TAO), EC/IC Bypass, MoyaMoya surgery
  • Potential Economic savings by incorporating the BPM in your clinical practice

Presented By:

H. Frederick Bowman, Ph.D.

President & CEO

H.Frederick Bowman, Ph.D., is the inventor of the Company’s technology and the founder of Hemedex. 40+ years leadership experience in the development of thermal diffusion technologies and commercialization of medical devices. 25 yrs ME/BME faculty member, 2 yr program director NSF and first employee of the Harvard-MIT Division of Health Sciences and Technology. 20 patents, 120 papers/abstracts. Click here for full bio.
.

Scott D. Greenwald, Ph.D.

Vice President of Technology

Scott Greenwald, Ph.D., VP of Technology. 20+ yrs leading research in the development of patient monitoring technologies at Hemedex, and formerly Covidien and Aspect Medical Systems, Inc. He is a co-inventor of 3 novel patient monitoring technologies (BIS, CVI, ATR), co-author of 8 US Patents, and co-author of 100+ publications. Trained at Duke, MIT and Harvard. Click here for full bio.

 

Key Learning Objectives

  • Recognize the value of quantifying perfusion in managing neurocritical care and neurosurgery patients
  • Review clinical applications of the Bowman Perfusion Monitor in neurocritical care
  • Discover clinical and economic benefits of perfusion monitoring in neurocritical care
  • Learn the scientific underpinnings of the technology and its validation

This webinar is aimed at clinicians who manage and care for patients with injuries resulting in compromised blood flow and would like to learn about real-time, absolute measurements of cerebral blood flow.

Click here to register now for FREE!.

 

About Hemedex, Inc.:

Hemedex, Inc. manufactures patient monitoring technology, the Bowman Perfusion Monitor®, for quantifying tissue blood flow. The Company’s patented technology provides clinicians with a powerful tool, which can provide an early warning of compromised blood flow and help target appropriate therapies rapidly and accurately. Data from the Bowman Perfusion Monitor helps guide physicians in implementing effective treatments quickly, creating the potential to improve patient outcomes and lower costs. Hemedex’s technology addresses unmet needs in many clinical areas such as neurocritical care (e.g., TBI, SAH), neurosurgery (e.g., TAO, EC-IC Bypass, Moya Moya), reconstructive surgery and organ transplantation, among others.  For more information, visit www.hemedex.com.

 

Communications Team
Hemedex Inc.
sblair@hemedex.com
617 577 1759 X 46